S100A8 and psoriasis: Elevated S100A8/A9 levels in these studies were associated with increased risk for cardiovascular disease [10, 27] implicating that increased S100A8/A9 serum concentrations could be a marker of systemic inflammation rather than skin inflammation in individuals with psoriasis.